Fresenius Medical Care's Results Are Solid But U.S. Dialysis Treatment Growth Disappoints -- Market Talk

Dow Jones
2025/05/06

0704 GMT - Fresenius Medical Care's better-than-expected results are solid but its U.S. dialysis treatment growth disappoints, Deutsche Bank analysts say in a note. The German dialysis company's closely watched underlying U.S. same-market treatment growth was flat due to a severe flu season leading to higher mortality among potential patients, the analysts say. Its backed outlook is a positive but foreign-currency exchanges should still put pressure on consensus earnings estimates, they say. (helena.smolak@wsj.com)

 

(END) Dow Jones Newswires

May 06, 2025 03:06 ET (07:06 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10